Pharmaceutical Glycerin Based Products Market to Grow at a CAGR of 12.1% During 2025 to 2035; Driven by Rising Demand for Pharmaceutical Applications and Increasing Use of Glycerin-Based Products

Pharmaceutical Glycerin Based Products Market Highlights

Pharmaceutical Glycerin Based Products Market was estimated at 0.2466 USD Billion in 2024. The pharmaceutical glycerin industry is projected to grow from USD 0.2765 Billion in 2025 to USD 0.8665 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 12.1% during the forecast period 2025 - 2035

The market for pharmaceutical glycerin-based products grows due to their use in various medications, creams, and ointments. Glycerin's properties as a moisturizer and excipient drive its incorporation into pharmaceutical formulations, contributing to market growth.

MRFR recognizes the following companies as the key players in the global pharmaceutical glycerin based products market— Capsugel, dupoint, AbbVie Inc, Croda International plc, Emery Oleochemicals, Johnson and Johnson, Bausch Health Companies Inc., Abbott Laboratories, Takeda Pharmaceutical Company, The Dow Chemical Company, Takeda Pharmaceutical Company Ltd.

Segment Analysis

The global pharmaceutical glycerin based products market has been segmented drug type.

On the basis of drug type, the market is segmented into dermatological, opthalmic, cough remidies, glycerine rectal and angina. The dermatological segment dominated the market in 2022. Glycerin is a frequent ingredient in dermatological products used to treat and manage a variety of conditions because of its hydrating and moisturizing properties.

Regional Analysis

The global pharmaceutical glycerin based products market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe pharmaceutical glycerin based products market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The pharmaceutical glycerin based products market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World pharmaceutical glycerin based products market comprises of Middle East, Africa, and Latin America.

The North America pharmaceutical glycerin based products market dominated this market in 2022 (45.80%). Glycerin-based topical medicines are made by pharmaceutical companies in North America for conditions like eczema and psoriasis. Different treatments aim to reduce the itching, redness, and inflammation caused by various skin disorders. The demand for effective and safe treatments for chronic skin problems is what is fueling the growth of this market segment.

Moreover, Europe holds the second-largest market share for glycerin-based pharmaceutical products. In Europe, glycerin-based products that offer gentle, all-natural skincare treatments are in high demand. In accordance with the region's concentration on skincare products that are both safe and effective, consumers in Europe favor products with few chemicals and allergens. Due of its moisturizing properties, glycerin is a favored component in these formulations.

Additionally, the Asia-Pacific pharmaceutical glycerin based products market is expected to grow at the fastest CAGR from 2023 to 2032. In many Asian cultures, natural and herbal remedies are valued. Glycerin is suitable for formulations that adhere to customs and preferences because it can be generated from plant sources.

Furthermore, the rest of the world's pharmaceutical glycerin based products market is divided into the Middle East, Africa, and Latin America. The pharmaceutical glycerin-based products market in Latin America is on the rise, driven by its use in medications and skincare items. Glycerin's moisturizing properties and its incorporation into pharmaceutical formulations fuel market demand in the region.

Key Findings of the Study

• he market is witnessing a rising demand for natural ingredients, particularly in North America, which remains the largest market.


• Advancements in formulation technologies are enhancing the efficacy and safety of glycerin-based products, especially in dermatological applications.


• There is a notable focus on personalized medicine, with Asia-Pacific emerging as the fastest-growing region in this sector.


• Key market drivers include the increasing adoption of glycerin in pharmaceuticals and the growing demand for non-toxic and eco-friendly products.